MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

share price movement, page-3

  1. 5,260 Posts.
    lightbulb Created with Sketch. 242
    Hi Ezogbi,

    Well, I'm an investor and I'd like to flatter myself that I have a pretty good understanding of what's going on with the company, its product pipeline and with ACV1 in particular.

    There is nothing that the general "market" knows that I don't. What you have is a collection of people with different strategies and goals. Some are short term and some are long term.

    I'm long term. I will hold this stock through any trading halt, any announcement and beyond. I am VERY confident of a huge upside after an announcement that will be gratifying to us who have hung in there in the face of an adverse market.

    Short term traders want to hold the stock in the period leading up to the halt and get out just before. They awnt to be in the stock for days, not weeks or mnths, to say nothing of years. When the release of the results was pushed back, these kind of investors took their money out. They need it elsewhere, and may come back in later in the week or next week as we get closer to mid-month.

    These people don't care about the results, they don't really even care what business Metabolic is in. They only want to profit on a potential short-term speculative run-up.

    Bottom line: Don't worry about these short term trends. They are meaningless in the long and medium term.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.